Review article: Pancreatic function testing

Alimentary Pharmacology and Therapeutics

Volumn 17, Issue 6, 2003, Pages 733-750

  Chowdhury, R S ^a   Forsmark, C E ^a,b  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENTIROMIDE; TRIACYLGLYCEROL;

CHRONIC PANCREATITIS; COMPUTER ASSISTED TOMOGRAPHY; COST; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; ENDOCRINE GLAND; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; EXOCRINE GLAND; HUMAN; PANCREAS FUNCTION TEST; PRIORITY JOURNAL; REVIEW; SCHILLING TEST;

4-AMINOBENZOIC ACID; BREATH TESTS; CHRONIC DISEASE; ENDOPEPTIDASES; ENZYMES; FATS; FECES; FLUORESCEINS; HUMANS; PANCREAS; PANCREATIC FUNCTION TESTS; PANCREATITIS; SCHILLING TEST; TRIGLYCERIDES;

EID: 0037444877     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2003.01495.x     Document Type: Review

References (170)

1. Layer P, Yamamoto H, Kalthoff L, Clain JE, Bakken LJ, DiMagno EP. The different courses of early- and late-onset idiopathic and alcoholic chronic pancreatitis. Gastroenterology 1994; 107(5): 1481-7.
2. Owyang C. Chronic pancreatitis. In: Yamada T. ed. Textbook of Gastroenterology. Philadelphia: Lippincott Williams & Wilkins, 1999: 2151-77.
3. Pandol SJ. Pancreatic physiology and secretory testing. In: Feldman M, Sleisenger MH, Scharschmidt BF, eds. Gastrointestinal and Liver Disease. Philadelphia: WB Saunders. 1998: 771-82.
4. Niederau C, Grendell JH. Diagnosis of chronic pancreatitis. Gastroenterology 1985; 88: 1973-95.
5. Forsmark CE. The diagnosis of chronic pancreatitis. Gastrointest Endosc 2000; 52(2): 293-8.
6. Boeck WG, Adler G, Gress TM. Pancreatic function tests: when to choose, what to use. Current Gastroenterol Rep 2001; 3: 95-100.
7. Lankisch PG. Exocrine pancreatic function tests: progress report. Gut 1982; 23: 777-98.
8. Lagerloef HO. Pancreatic function and pancreatic disease: studied by means of secretin. Acta Med Scand 1942; 128(Suppl.): 1-289.
9. Dreiling DA, Hollander F. Studies in pancreatic function. 1. Preliminary series of clinical studies with the secretin test. Gastroenterology 1948; 11: 714-29.
10. Wormsely KG. Further studies of the response to secretin and pancreozymin in man. Scand J Gastroenterol 1971; 6: 343-50.
11. Duerr HK, Bode HCh, Ammann RW. Interlaboratory quality control of laboratory data in the secretin-pancreozymin test. Report of a pilot study. Irish J Med Sci 1977: 146(Suppl. 1): 11-2.
12. Ochi K. Mizushima T. Harada H, Matsumoto S. Matsumura N. Seno T. Chronic pancreatitis: functional testing. Pancreas 1998; 16(3): 343-8.
13. Committee of the Japanese Society of Gastroenterology. Interim report of the committee for the standardization of secretin test. J Jpn Soc Gastroenterol 1985; 82: 3051-2.
14. Committee of the Japanese Society of Gastroenterology. Final report of the committee for the standardization of secretin test. J Jpn Soc Gastroenterol 1987; 84: 1920-4.
15. Lundh G. Pancreatic exocrine function in neoplastic and inflammatory disease: a simple and reliable new test. Gastroenterology 1962; 42: 275-80.
16. Wormsely KG. Tests of pancreatic secretion. Clin Gastroenterol 1978; 7: 529-44.
17. Mottaleb A, Kapp F. Noguera ECA. Kellock TD. Wiggins HS. Walter S. The Lundh test in the diagnosis of pancreatic disease: a review of five years experience. Gut 1973; 14: 835-41.
18. Braganza JM. Rao JJ. Disproportionate reduction in tryptic response to endogenous compared with exogenous stimulation in chronic pancreatitis. Br Med J 1978; 2: 392-4.
19. Gyr K, Agrawal NM. Felsenfeld O. Font RG. Comparative study of secretin and Lundh test. Am J Dig Dis 1975; 20: 506-12.
20. Moeller DD. Dunn GD, Klotz AP. Comparison of the pancreozymin-secretin test and Lundh test meal. Am J Dig Dis 1972; 17: 799-805.
21. Sun DCH, Shay H. Value of combined study of serum enzymes and duodenal contents after secretin in the diagnosis of disease of the pancreas. Gastroenterology 1957; 32: 212-31.
22. Bordalo O, Noronha M, Lamy J, Dreiling DA. Standard and augmented secretin testing in chronic pancreatic alcoholic disease. Am J Gastroenterol 1975; 64: 125-32.
23. Takebe T, Koike D, Yokoyama Y. Modern trends in biochemical tests of the pancreas: CS test and S test. Biliary Tract Pancreas 1986; 7: 583-8.
24. Pererson H. The effect of pure natural secretin on the bicarbonate secretion in the duodenum in man. Scand J Gastroenterol 1970; 5: 105-11.
25. Burton P, Evans DG. Harper AA. A test of pancreatic function in man based on the analysis of duodenal contents after administration of secretin and pancreozymin. Gut 1960; 1: 111-24.
26. Isenberg JI, Grossman MI. Comparison of subcutaneous and intravenous secretin in man. Gastroenterology 1969; 56: 88-91.
27. Banwell JG, Northam BE, Cooke WT. Secretory response of the human pancreas to continuous intravenous infusion of secretin. Gut 1967; 8: 50-7.
28. Wormsely KG. Response to secretin in man. Gastroenterology 1968; 54: 197-209.
29. Farini R, Del-Favero G, Adorati M, et al. Comparison between bolus injection and infusion of secretin and pancreozymin in the diagnosis of chronic pancreatic disease (one hour test). Acta Hepato-Gastroenterol 1977; 24(6): 462-8.
30. Bordalo O, Noronha M, Lamy J, Dreiling D. The secretin test with the standard dose and high dose in chronic pancreatitis. Minerva-Med 1976; 67(55): 3599-606.
31. Sun DCH. Normal values for the pancreozymin-secretin test. Gastroenterology 1963; 44: 602-6.
32. Zieve L, Silvis SE, Mulford B. Blackwood WD. Secretion of pancreatic enzymes. Response to secretin and pancreozymin. Am J Dig Dis 1966; 9: 671-84.
33. Bank S, Marks IN, Moshal MG, Efron G, Silber R. The pancreatic function test - method and normal values. S Afr Med J 1963; 37: 1061-6.
34. Wormsely KG. The response to infusion of a combination of secretin and pancreozymin in health and disease. Scand J Gastroenterol 1969; 4: 623-32.
35. Banwell JG, Northan BE, Cooke WT. Secretory response of the human pancreas to continuous intravenous infusion of pancreozymin-cholecystokinin (Cecekin). Gut 1967; 8: 380-7.
36. Conwell DL, Zuccaro G, Morrow J. et al. A new cholecystokinin (CCK) stimulated pancreatic function test distinguishes normals from chronic pancreatitis. Gastroenterology 2000; 118(4): A2165(Abstract).
37. Gullo L, Costa PL, Fontana G, Labo G. Investigation of exocrine pancreatic function by continuous infusion of caerulein and secretin in normal subjects and in chronic pancreatitis. Digestion 1976; 14: 97-107.
38. Basso N, Giri S, Improta G. External pancreatic secretion after bombesin infusion in man. Gut 1975; 16: 994-8.
39. Suzuki T, Suzuki K, Kobayashi E. Comparison of utility between pancreozymin-secretin tests in patients with chronic pancreatitis. J Jpn Soc Gastroenterol 1986; 83: 2209-15.
40. Somogyi L, Cintron M, Toskes P. Synthetic porcine secretin is highly accurate in pancreatic testing in individuals with chronic pancreatitls. Pancreas 2000; 21(3): 262-5.
41. Ross SO. Cintron M, Toskes PP. Comparison of biologic porcine secretin, synthetic porcine secretin, and synthetic human secretin in pancreatic function testing. Pancreas 2000; 21(4); 473(Abstract).
42. Petersen H, Eerstad A. Comparison of response to intravenous injection and infusion of secretin in man. Scand J Gastroenterol 1972; 7: 453-9.
43. Wormsely KG. Aspects of duodeno-gastric reflux in man. Gut 1972; 13: 243-50.
44. Petersen H, Myren J. Secretin dose-response in health and chronic pancreatic inflammatory disease. Scand J Gastroenterol 1975; 10: 851-61.
45. Bartelheimer H. Quantitative fractionierte Pankreas- und Gallensaftuntersuchungen durch Anwendung einer dreiläufigen Doppelballonsonde. Dtsch Med Wochenschr 1953; 78: 993-5.
46. Delachaume-Salem E, Sarles H. Normal human pancreatic secretion in relation to age. Biol Gastroenterol 1970; 2: 135-46.
47. Lagerloef HO, Schuetz HB, Holmer S. A secretin test with high doses of secretin and correction for incomplete recovery of duodenal juice. Gastroenterology 1967; 52: 67-77.
48. Go VLW, Hofmann AF, Summerskill WHJ. Simultaneous measurements of total pancreatic, biliary and gastric outputs in man using a perfusion technique. Gastroenterology 1970; 58: 321-8.
49. Worning H. Pancreatic function tests. Rev Esp Enferm Apar Dig 1978; 53(Suppl.): 155-78.
50. Petersen H, Berstad A, Myren J. Bicarbonate response to graded doses of secretin in patients with different gastric acid secretory capacity. Acta Hepato-Gastroenterol 1973; 20: 421-7.
51. Thjodleifsson B. Wormsley KG. Aspects of the effects of metiamide on pentagastrin stimulated and basal gastric secretion of acid and pepsin in man. Gut 1975; 16: 501-8.
52. Lankisch PG. Creutzfeldt W. Effects of synthetic and natural secretin on the function of the exocrine pancreas in man. Digestion 1981; 22: 61-5.
53. Thomas FB, Sinar D, Caldwell JH. Mekhjian HS, Falko JM. Stimulation of pancreatic secretion of water and electrolytes by furosemide. Gastroenterology 1977; 73: 221-5.
54. Tympner F. Domschke S. Domschke W, Classen M, Demling L. Reproducibility of the response to secretin and secretin plus pancreozymin in man. Scand J Gastroenterol 1974; 9: 377-81.
55. Denyer E. Cotton PB. Pure pancreatic juice studies in normal subjects and patients with chronic pancreatitis. Gut 1979; 20: 89-97.
56. Ochi K, Harada H. Mizushima T, Tanaka J, Matsumoto S, Intraductal secretin test is as useful as duodenal secretin test in assessing exocrine pancreatic function. Dig Dis Sci 1997; 42: 492-6.
57. Gregg JA. The intraductal secretin test: an adjunct to ERCP. Gastrointest Endosc 1982; 28: 199-203.
58. Amann S. Newman MB, Toskes PP, Relationship of the etiology of chronic pancreatitis to the time to reach peak bicarbonate secretion in duodenal aspirates after secretin stimulation. Gastroenterology 1999; 116: G4811.
59. Pollack BJ, Forsmark CE. Adjunct diagnosis of pancreatic disease and pancreatic physiology. In: Sivak MV Jr. ed. Gastroenterologic Endoscopy. Philadelphia: WB Saunders. 2000; 1116-25.
60. Bornschein W. A fast endoscopic test of pancreatic secretion (endoscopic secretin-caerulein-test). Z Gastroenterol 1978; 16(9): 582-92.
61. Ceryak S, Steinberg W, Marks ZH, Ruiz A. Feasibility of an endoscopic secretin test: preliminary results. Pancreas 2001; 23(2): 216-23.
62. Hayakawa T, Kondo T. Shibata T, Noda A, Suzuki T, Nakano S. Relationship between pancreatic exocrine function and histological changes in chronic pancreatitis. Am J Gastroenterol 1992; 87(9): 1170-4.
63. Rolny P, Jagenburg R. The secretin-CCK test and a modified Lundh test. A comparative study. Scand J Gastroenterol 1978; 13(8): 927-31.
64. Heij HA, Obertop H, van Blankenstein M, ten Kate FW, Westbroek DL. Relationship between functional and histological changes in chronic pancreatitis. Dig Dis Sci 1986; 31(10): 1009-13.
65. Waye JD, Adler M, Dreiling DA. The pancreas. A correlation of function and structure. Am J Gastroenterol 1978; 69: 176-81.
66. Rolny P, Lukes PJ, Gamklou R. Jagenburg R, Nilson A. A comparative evaluation of endoscopic retrograde pancreatography and secretin-CCK test in the diagnosis of pancreatic disease. Scand J Gastroenterol 1978; 13:777-81.
67. Nakano S, Horiguchi T, Takeda T, Suzuki T, Nakajima S. Comparative diagnostic value of endoscopic pancreatography and pancreatic function tests. Scand J Gastroenterol 1974; 9: 383-90.
68. Bozkurt T, Braun U, Leferink S, Gilly G, Lux G. Comparison of pancreatic morphology and exocrine functional impairment in patients with chronic pancreatitis. Gut 1994; 35: 1132-6.
69. Heij HA, Obertop H. Schimtz PIM. van Blankenstein M, Westerbroek DL. Evaluation of the secretin-cholecystokinin test for chronic pancreatitis by discriminant analysis. Scand J Gastroenterol 1986; 21: 35-40.
70. Domínguez-Munoz JE, Manes G, Pieramico O, Büchler M. Malfertheiner P. Effect of pancreatic ductal and parenchymal changes on exocrine function in chronic pancreatitis. Pancreas 1995; 10(1): 31-5.
71. Braganza JM, Hunt LP, Warwick F. Relationship between pancreatic exocrine function and ductal morphology in chronic pancreatitis. Gastroenterology 1982; 82: 1341-7.
72. Lankisch PG, Seidensticker F, Otto J, et al. Secretin-pancreozymin test (SPT) and endoscopic retrograde cholangiopancreatography (ERCP): both are necessary for diagnosing or excluding chronic pancreatitis. Pancreas 1996; 12(2): 149-52.
73. Malfertheiner P, Büchler M, Stanescu A, Ditschuneit H. Exocrine pancreatic function in correlation to ductal and parenchymal morphology in chronic pancreatitis. Hepato-Gastroenterol 1986: 33: 110-4.
74. Kitagawa M, Naruse S, Ishiguro H, Nakae Y. Kondo T, Hayakawa T. Evaluating exocrine function tests for diagnosing chronic pancreatitis. Pancreas 1997; 15(4): 402-8.
75. Girdwood AH. Hatfield ARW. Bornman PC, Denyer ME, Kottler RE, Marks IN. Structure and function in noncalcific pancreatitis. Dig Dis Sci 1984; 29(8): 721-6.
76. Lambiase L, Forsmark CE, Toskes PP. Secretin test diagnoses chronic pancreatitis earlier than ERCP. Gastroenterology 1993; 104: A315(Abstract).
77. Zuccaro G, Conwell DL, Vargo J, Dumot J, John H, Charles OM. The role of endoscopic ultrasonography (EUS) in the diagnosis of early and advanced chronic pancreatitis (CP). Gastroenterology 2000; 118: A674(Abstract).
78. Raimondo M, Wiersema MJ, Vazquez-Sequeiros E, DiMagno E. Endoscopic ultrasound (EUS) may not be as sensitive as previously thought to diagnose chronic pancreatitis (CP). A preliminary correlation study with CCK pancreatic function test. Gastrointest Endosc 2001; 53: AB69.
79. Chowdhury RS, Bhutani MS, Mishra G. Forsmark CE. Toskes PP. Comparative analysis of pancreatic function testing versus morphological assessment (by EUS) for the evaluation of chronic unexplained abdominal pain (UAP). Gastroenterology 2001; 120(5): A647(Abstract).
80. Chowdhury RS, Forsmark CR. Bhutani MS, Toskes PP. The evaluation of unexplained pain of presumed pancreatic origin. Gastroenterology 2001; 120(5): A760(Abstract).
81. Blau M, Manske RF. The pancreas specificity of Se-selenomethionine. J Nucl Med 1961; 2: 102-5.
82. Youngs GR, Agnew JE. Levin GE, Bouchier IAD. Radioselenium in duodenal aspirate as an assessment of pancreatic exocrine function. Br Med J 1971; 2: 252-5.
83. Shichiri M, Etani N, Yoshida M. Radioselenium pancreozymin-secretin test for pancreatic exocrine secretion. Am J Dig Dis 1975; 20: 460-8.
84. Pointer H, Kletter K. Evaluation of Se-selenomethionine test for pancreatic diseases. Digestion 1980; 20: 225-33.
85. Pointner H, Kinast H, Flegel U. Se-selenomethionine excretion in bile and pancreatic juice. Digestion 1975; 12: 61-4.
86. Boyd EJS, Wood H. Clarke G, Neill GD, Hutchinson F. Pancreatic synthetic rates: a new test of pancreatic function. Scand J Gastroenterol 1982; 17: 225-31.
87. Domschke S, Heptner G, Kolb S, Sailer D. Schneider MU. Domschke W. Decrease in plasma amino acid level after secretin and pancreozymin as an indicator of exocrine pancreatic function. Gastroenterology 1986; 90(4): 1031-8.
88. Dzieniszewski J, Jorosz M, Kunachowicz H. Klys W. Level of amino acids in blood plasma as a test for exocrine pancreatic function. Wiad Lek 1990; 43(9-10): 387-96.
89. Maringhini A, Nelson DK, Jones JD, Dimagno EP. Is the plasma amino acid consumption test an accurate test of exocrine pancreatic insufficiency? Gastroenterology 1994; 106(2): 488-93.
90. Borovicka J, Schwizer W, Remy B, Fried M. CCK induced changes in plasma amino acid concentration (AA) are not a valid test for pancreatic insufficiency (PI). Gastroenterology 1993; 104: A296(Abstract).
91. Jacobson DG. Currington C, Connery K, Toskes PP. Trypsin like immunoreactivity as a test for pancreatic insufficiency. N Engl J Med 1984; 310: 1307-8.
92. Borgstroem A. Wehlin L. Correlation between serum concentration of three specific exocrine pancreatic proteins and pancreatic duct morphology at ERCP examinations. Scand J Gastroenterol 1984; 19: 220-7.
93. Andriulli A, Masoero G, Felder M, et al. Circulating trypsin-like immunoreactivity in chronic pancreatitis. Dig Dis Sci 1981; 26: 532-7.
94. Elias E, Reshaw M, Wood T. Diagnostic importance of changes in circulating concentrations of immunoreactive trypsin. Lancet 1977; I: 66-8.
95. Koop H, Lankissich PG. Stoeckmann F, Arnod R. Trypsin radioimmunoassay in the diagnosis of chronic pancreatitis. Digestion 1980; 20: 151-6.
96. Lake-Bakaar G, McKavanagh S, Gatus B, Summerfield JA. The relative values of serum immunoreactive trypsin concentration and total amylase activity in the diagnosis of mumps, chronic renal failure and pancreatic diseases. Scand J Gastroenterol 1980; 15: 97-101.
97. Felber JP, Bambule-Dick J, Carrel O, Granduillaume P, Gauthier E. Decreased plasma trypsin in juvenile diabetics. Diabetologica 1978; 14: 231(Abstract).
98. Owyang C. Scarpello JH, Vinik AI. Correlation between pancreatic enzyme secretion and plasma concentration of human pancreatic polypeptide in health and in chronic pancreatitis. Gastroenterology 1982; 83(1 Part 1): 55-62.
99. Stern AI. Hansky J. Secretin stimulated pancreatic polypeptide: a test for chronic pancreatitis. Aust NZ J Med 1981: 11(4): 351-4.
100. Matsumoto M, Wakasugi H, Ibayashi H. Plasma human pancreatic polypeptide response in chronic pancreatitis. Gastroenterol Jpn 1982; 17(1): 25-30.
101. Anderson BN, Hagen C, Klein HC, Stadil F. Worning H. Correlation between exocrine pancreatic secretion and serum concentration of human pancreatic polypeptide in chronic pancreatitis. Scand J Gastroenterol 1980; 15(6): 699-704.
102. Valenzuela JE, Taylor IL, Walsh JH. Pancreatic polypeptide response in chronic pancreatitis. Dig Dis Sci 1979; 24(11): 862-4.
103. Stern I. Robert-Thompson IC, Hansky J. Correlation between pancreatic polypeptide response to secretin and ERCP findings in chronic pancreatitis. Gut 1982; 23(3): 235-8.
104. Haverback BJ, Dyce BJ, Gutentag PJ, Montgomery DW. Measurement of trypsin and chymotrypsin in stool: a diagnostic test for pancreatic exocrine function. Gastroenterology 1963: 44: 588-97.
105. Goldberg DM. Proteases in the evaluation of pancreatic function and pancreatic disease. Clin Chim Acta 2000: 291(2): 201-21.
106. Dominguez-Munoz JE, Hieronymus C, Sauerbruch T. Malfertheiner P. Fecal elastase test: evaluation of a new noninvasive pancreatic function test. Am J Gastroenterol 1995; 90: 1834-7.
107. Stein J, Jung M, Sziegoleit A, Zeuzem S, Caspary WV, Lembcke B. Immunoreactive elastase 1: clinical evaluation of a new noninvasive test of pancreatic function. Clin Chem 1996; 42: 222-6.
108. Loser C, Mollgaard A, Folsch UR. Fecal elastase 1. A novel, highly sensitive and specific tubeless pancreatic function test. Gut 1996; 39: 580-6.
109. Kataoka K, Hosoda M, Yasuda H, Sakagami J, Kato M, Kashima K. Assessment of exocrine pancreatic dysfunction in chronic pancreatitis. Digestion 1999: 60(Suppl. 1): 86-92.
110. Katschinski M, Schirra J, Bross A. Goke B. Arnold R, Duodenal secretion and fecal excretion of pancreatic elastase-1 in healthy humans and patients with chronic pancreatitis. Pancreas 1997; 15(2): 191-200.
111. Kataoka K, Yamane Y, Kato M, Kashima K. Diagnosis of chronic pancreatitis using noninvasive tests of exocrine pancreatic function - comparison to duodenal intubation tests. Pancreas 1997; 15(4): 409-15.
112. Cavallini G, Benini L, Brocco G, et al. The fecal chymotrypsin photometric assay in the evaluation of exocrine pancreatic capacity. Comparison with other direct and indirect pancreatic function tests. Pancreas 1989; 4(3): 300-4.
113. Dyck W, Ammann R. Quantitative determination of fecal chymotrypsin as a screening test for pancreatic exocrine insufficiency. Am J Dig Dis 1965; 10: 530-45.
114. Muller L, Wisniewski ZS, Kansky J. The measurement of fecal chymotrypsin: a screening test for pancreatic exocrine insufficiency. Aust Ann Med 1970; 19: 47-9.
115. Ammann RW, Tagwercher E, Dashiwagi H. Rosenmund H. Diagnostic value of the fecal chymotrypsin test in pancreatic insufficiency particularly chronic pancreatitis: correlation with the pancreozymin-secretin test, fecal fat excretion and final clinical diagnosis. Digestion 1981; 21: 281-9.
116. Duerr HK, Otte M, Forell MM, Bode JC. Fecal chymotrypsin: a study on its diagnostic value by comparison with the secretin-cholecystokinin test. Digestion 1978; 17: 404-9.
117. Scotta MS, Marzani MD, Maggiore G, De-Giacomo C. Melzi-D'Eril GV, Moratti R. Fecal chymotrypsin: a new diagnostic test for exocrine pancreatic insufficiency in children with cystic fibrosis. Clin Biochem 1985; 18(4): 233-4.
118. De-Pedro C, Codoceo R, Vazquez P, Hernanz A. Fecal chymotrypsin levels in children with pancreatic insufficiency. Clin Biochem 1986; 19(6): 338-40.
119. Sale JK, Goldberg DM. Thjodleifsson B. Wormsley KG. Trypsin and chymotrypsin in duodenal aspirates and feces in response to secretin and cholecystokinin and pancreozymin. Gut 1974; 15: 132-8.
120. Goldberg DM. Proteases in the evaluation of pancreatic function and pancreatic disease. Clin Chim Acta 2000; 291: 201-21.
121. Scheefers-Borchel U. Scheefers H. Arnold R, Fischer P. Sziegoleit A. Pancreatic elastasel Parameter for the diagnosis of chronic and acute pancreatitis. Lab Med 1992; 16: 427-32.
122. Sziegoleit A, Krause E, Klör HU, Kranacher L, Linder D. Elastase 1 and chymotrypsin B in pancreatic juice and feces. Clin Biochem 1989; 22: 85-9.
123. Sziegoleit A, Linder D. Studies on the sterol-binding capacity of human pancreatic elastase. Gastroenterology 1991; 100: 768-74.
124. Stein J, Jung M, Sziegoleit A, Zeuzem S, Caspary WF, Lembcke B. Immunoreactive elastase 1: clinical evaluation of a new noninvasive test of pancreatic function. Clin Chem 1996; 42(2): 222-6.
125. Lüth S, Teyssen K, Forssmann K, Kölbel C, Krummenauer F, Singer MV. Fecal elastase-1 determination: 'Gold Standard' of indirect pancreatic function tests? Scand J Gastroenterol 2001; 10: 1092-9.
126. Amann ST, Bishop M, Curington C, Toskes PP. Fecal pancreatic elastase-1 is inaccurate in the diagnosis of chronic pancreatitis. Pancreas 1996; 13: 226-30.
127. Gullo L, Ventrucci M, Toassetti P, Migliori M, Pezzilli R. Fecal elastase-1 determination in chronic pancreatitis. Dig Dis Sci 1999; 44: 210-3.
128. Lankisch PG, Schmidt I, König H, Lehnick D, Knollmann R, Löhr M, Fecal elastase-1: not helpful in diagnosing chronic pancreatitis associated with mild to moderate exocrine pancreatic insufficiency. Gut 1998; 42: 551-4.
129. Löser C, Möllgaard A, Fölsch UR. Fecal elastase-1: a novel, highly sensitive and specific tubeless pancreatic function test. Gut 1996; 39: 580-6.
130. Gullo L. Fecal elastase-1 in chronic pancreatitis. Gut 1999; 44(2): 291-2.
131. Lankisch PG, Schmidt I. Fecal elastase-1 is not the indirect pancreatic function test we have been waiting for. Dig Dis Sci 2000; 45(1): 166-7.
132. Di Magno EP, Go VLW. Summerskill WHJ. Relations between pancreatic enzyme output and malabsorption in severe pancreatic insufficiency. N Engl J Med 1973; 288: 813-5.
133. Harada H, Shundo T, Ikubo I. Exocrine pancreatic function test by a synthetic peptide. In: Masuda M. ed. Pancreatic Function Diagnostant. New York: Igaku-shoin, 1980: 101-7.
134. Gyr K, The use of BT-PABA in pancreatic disease - a 5-year experience from Switzerland. In: Masuda M, ed. Pancreatic Function Diagnostant. New York; Igaku-shoin, 1980: 38-45.
135. Amman RW, Buehler H, Pei P. Comparative diagnostic accuracy of four tubeless pancreatic function tests in chronic pancreatitis. Scand J Gastroenterol 1982; 17: 997-1002.
136. 14CPABA in the assessment of pancreatic exocrine insufficiency. Digestion 1984; 29: 42-6.
137. Lankisch PG, Ehrhardt-Schmelzer S, Koop H, Caspery WF. Der NBT-PABA-Test in der Diagnostik dert exokrinen Pankreasinsuffizienz. Ein Vergleich mit dem Sekretin-Pankreozymin-Test, den Stuhlenzym-Bestimmungen und der quantitativen Stuhlfett-Analyse. Dtsch Med Wochenschr 1980; 105: 1418-23.
138. Toskes PP. Bentiromide as a test of exocrine pancreatic function in adult patients with pancreatic exocrine insufficiency. Determination of appropriate dose and urinary collection interval. Gastroenterology 1983; 85: 565-9.
139. Naruse S, Hayakawa T, Noda A. Diagnosis of pancreatic disease by a synthetic peptide. In: Masuda M, ed. Pancreatic Function Diagnostant. New York: Igaku-shoin, 1980: 88-92.
140. Ventrucci M, Gullo L, Daniele C, Priori P, Labo G. Pancreolauryl test for pancreatic exocrine insufficiency. Am J Gastroenterol 1983; 73: 86-9.
141. Gunkel U. Bitterlich N. Keim V. Value of combinations of pancreatic function tests to predict mild to moderate chronic pancreatitis. Z Gastroenterol 2001; 39(3): 207-11.
142. Leodolter A, Kahl S, Dominguez-Munoz JE, Gerards C, Glasbrenner B. Malfertheiner P. Comparison of two tubeless function tests in the assessment of mild-moderate exocrine pancreatic insufficiency. Eur J Gastroenterol Hepatol 2000; 12(12): 1335-8.
143. Lock G, Kadow R, Messmann H, Zirngibl H, Scholmerich J, Holstege A, Modified serum pancreolauryl test in chronic pancreatitis: evaluation in comparison to endoscopic retrograde pancreatography. Hepatogastroenterology 1997; 44(16): 1110-6.
144. Gullo L, Pezzili R, Ventrucci M. Diagnostic value of the amino acid consumption test in chronic pancreatitis. Pancreas 1996; 12(1); 64-7.
145. Glasbrenner B, Schon A, Klatt S, Beck H, Adler G. Clinical evaluation of the fecal elastase test in the diagnosis and staging of chronic pancreatitis. Eur J Gastroenterol Hepatol 1996; 8(11): 1117-20.
146. Dominguez-Munoz JE, Pieramico O, Buchler M. Malfertheiner P. Clinical utility of the serum pancreolauryl test in diagnosis and staging of chronic pancreatitis. Am J Gastroenterol 1993; 88(3): 1237-41.
147. Rosemeyer D, Brackmann P, de-Boer H, Freitag J, Koblitz DK, Muller K. 1,000 pancreolauryl tests: evaluation of sensitivity, specificity and use in clinical routine. Z Gastroenterol 1986; 24(10): 645-4.
148. Malfertheiner P, Peter M, Junge U, Ditschuneit H. Oral pancreas function test with FDL in the diagnosis of chronic pancreatitis. Kiln Wochenschr 1983; 61(4); 193-8.
149. Lankisch PG, Schreiber A, Otto J. Pancreolauryl test. Evaluation of a tubeless pancreatic function test in comparison with other indirect and direct tests for exocrine pancreatic function. Dig Dis Sci 1983; 28(6); 490-3.
150. Cavallini G, Piubello W, Brocco G, et al. Reliability of the Bz-Ty-PABA and the pancreolauryl test in the assessment of exocrine pancreatic function. Digestion 1983; 27(3): 129-37.
151. Kay G, Hine P, Braganza J. The pancreolauryl test. A method of assessing the combined functional efficacy of pancreatic esterase and bile salt in vitro? Digestion 1982; 24(4): 241-5.
152. Ventrucci M, Gullo L. Daniele C, Priori P, Labo G, Pancreolauryl test for pancreatic exocrine insufficiency. Am J Gastroenterol 1983; 78(12): 806-9.
153. Toskes PP, Hansel J, Cerda J, Deren L, Vitamin B12 malabsorption in chronic pancreatic insufficiency. Studies suggesting the presence of a pancreatic 'intrinsic factor'. N Engl J Med 1971; 248: 627-32.
154. Toskes PP, Deren JJ. Vitamin B12 absorption and malabsorption. Gastroenterology 1973; 65: 662-83.
155. Gueant JL, Champignuelle B. Gaucher P, Nicolas JP. Malabsorption of vitamin B12 in pancreatic insufficiency of the adult and of the child. Pancreas 1990; 5(5): 559-67.
156. Allen RH, Seetharam B, Podell E, Alpers DH. Effects of proteolytic enzymes on the binding of cobalamin to R protein and intrinsic factor. In vitro evidence that a failure to partially degrade R protein is responsible for cobalamin malabsorption in pancreatic insufficiency. J Clin Invest 1978; 61(1): 47-54.
157. Chen WL, Morishita R, Eguchi T, et al. Clinical usefulness of dual-label Schilling test for pancreatic exocrine function. Gastroenterology 1989; 96(5): 1337-45.
158. Brugge WR, Goff JS, Allen NC, Podell ER, Allen RH. Development of a dual label Schilling test for pancreatic exocrine function based on the differential absorption of cobalamin bound to intrinsic factor and R protein. Gastroenterology 1980; 78(5): 937-49.
159. Leung JWC, Frost RA, Burgess R, et al. Modified dual label Schilling test for pancreatic exocrine function. Clin Chim Acta 1988; 174: 93.
160. Newcomer AD, Hofmann AF, DiMagno EP. Thomas PJ, Carlson GL. Triolein breath test. Sensitive and specific tests for fat malabsorption. Gastroenterology 1979; 76: 6-13.
161. 13C-labelled trioctanoin breath test for exocrine pancreatic function test in patients after pancreatoduodenectomy. Am J Gastroenterol 1993; 88: 64-9.
162. 13C-labelled lipids: trioctanoin, triolein and palmitic acid breath test. Gastroenterology 1982; 82: 911-7.
163. 13C-hiolein-breath test. Gut 1996; 39: 668-74.
164. 14C-tripalmitin breath test as a diagnostic aid for fat malabsorption due to pancreatic insufficiency. J Nucl Med 1974; 15: 1125-9.
165. Goff JS, Two-stage triolein breath test differentiates pancreatic insufficiency from other causes of malabsorption. Gastroenterology 1982; 83: 44-6.
166. Cole SG, Rossi S, Stern A, Hoffmann AF. Cholesteryl octanoate breath test. Preliminary studies on a new noninvasive test of human pancreatic exocrine function. Gastroenterology 1987; 93: 1372-80.
167. 3H-oleic acid as a test of pancreatic digestive function. Scand J Gastroenterol 1984; 19; 161-6.
168. Ghoos YF, Vantreppen GR, Rutgeerts P, Schurmans PC, A mixed-triglyceride breath test for intraluminal fat digestive activity. Digestion 1981; 22: 239-47.
169. Vantreppen GR, Rutgeerts PJ, Ghoos YF, Hiele MI. Mixed triglyceride breath test: a noninvasive test of pancreatic lipase activity in the duodenum. Gastroenterology 1989; 96: 1126-34.
170. 13C-mixed triglyceride breath test as an indirect pancreatic function test. Scand J Gastroenterol 1998; 33: 327-34.